- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 491/107 - Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
Patent holdings for IPC class C07D 491/107
Total number of patents in this class: 2337
10-year publication summary
|
128
|
136
|
178
|
186
|
198
|
216
|
218
|
224
|
211
|
90
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 10338 |
64 |
| Hoffmann-La Roche Inc. | 3726 |
50 |
| VALO Health, Inc. | 186 |
44 |
| Bristol-myers Squibb Company | 4789 |
40 |
| F. Hoffmann-La Roche AG | 7847 |
38 |
| Merck Sharp & Dohme LLC | 3737 |
36 |
| Takeda Pharmaceutical Company Limited | 2718 |
34 |
| Gilead Sciences, Inc. | 2207 |
32 |
| Merck Patent GmbH | 5669 |
31 |
| Vertex Pharmaceuticals Incorporated | 1589 |
28 |
| Amgen Inc. | 4383 |
24 |
| Kala bio, Inc. | 42 |
24 |
| Shionogi & Co., Ltd. | 866 |
21 |
| Boehringer Ingelheim International GmbH | 4494 |
19 |
| Genentech, Inc. | 4090 |
18 |
| AstraZeneca AB | 2830 |
17 |
| Bayer AG | 3470 |
17 |
| Bayer Pharma AG | 1025 |
17 |
| Pfizer Inc. | 3375 |
16 |
| The Broad Institute, Inc. | 1948 |
15 |
| Other owners | 1752 |